Literature DB >> 2218892

Local recurrence after curative resection of colorectal adenocarcinoma.

F Michelassi1, L Vannucci, J J Ayala, R Chappel, R Goldberg, G E Block.   

Abstract

A total of 853 patients with 861 colorectal adenocarcinomas were operated on at our institution between 1965 and 1981. Complete follow-up information was obtained in all but six patients (99.4%), and all available histologic slides were reviewed to determine pathologic stage and characteristics. Six hundred fifty-one patients (76.3%) underwent a potentially curative procedure, and their operative mortality rate was 2.8%. Of the 627 patients available for analysis, 50 (8%) had a local recurrence. The median time to local recurrence was 18 months, and only 16% of local recurrences were diagnosed 5 years after the original resection. Median survival of patients with a local recurrence was 3 1/2 years from the original resection, and 16 patients (32%) survived 5 years or longer. A multivariate logistic regression analysis was conducted to examine the influence of several clinical and pathologic characteristics on local recurrence among Dukes' stages B and C adenocarcinomas (n = 539) after exclusion of patients with synchronous tumors (n = 8), postoperative deaths (n = 18), loss to follow-up (n = 6), or incomplete data (n = 11). This analysis revealed that the local recurrence rate was significantly related to depth of invasion (B1 + C1 = 0%; B2 + C1 = 10%; p less than 0.01), site of origin (right plus transverse colon = 6%; left plus rectosigmoid colon = 10%; rectum = 12%; p less than 0.05), and lymphatic or capillary microinvasion (absent, 6%; present, 14%; p less than 0.05). This analysis attempts to identify patients at high risk for development of local recurrent disease to select candidates for postoperative adjuvant therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2218892

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Intraperitoneal versus intravenous CPT-11 given intra- and postoperatively for peritoneal carcinomatosis in a rat model.

Authors:  Arndt Hribaschek; Roger Kuhn; Matthias Pross; Frank Meyer; Jörg Fahlke; Karsten Ridwelski; Carsten Boltze; Hans Lippert
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 2.  Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.

Authors:  Takeshi Nishikawa; Eiji Sunami; Toshiaki Tanaka; Junichiro Tanaka; Tomomitsu Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Soichiro Ishihara; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

3.  Surgical management of locally advanced and locally recurrent colon cancer.

Authors:  Ron G Landmann; Martin R Weiser
Journal:  Clin Colon Rectal Surg       Date:  2005-08

4.  Treatment of rectal cancer by low anterior resection with coloanal anastomosis.

Authors:  P B Paty; W E Enker; A M Cohen; G Y Lauwers
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

5.  Surgical treatment for the recurrence of colorectal cancer.

Authors:  Y Yamamoto; H Imai; S Iwamoto; Y Kasai; T Tsunoda
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer.

Authors:  R E Frank; T J Saclarides; S Leurgans; N J Speziale; E A Drab; D B Rubin
Journal:  Ann Surg       Date:  1995-12       Impact factor: 12.969

7.  Serosal imprint cytology in colonic cancer: a simple staging technique.

Authors:  P D Murphy; J Hoffman; C Karczenski; E L Gilliland; A L Peel; T I Rosenberg
Journal:  Int J Colorectal Dis       Date:  1994-05       Impact factor: 2.571

8.  Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.

Authors:  David Azria; Frederic Bibeau; Nicolas Barbier; Abderrahim Zouhair; Claire Lemanski; Philippe Rouanet; Marc Ychou; Pierre Senesse; Mahmut Ozsahin; André Pèlegrin; Jean-Bernard Dubois; Simon Thèzenas
Journal:  BMC Cancer       Date:  2005-06-20       Impact factor: 4.430

9.  Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer.

Authors:  O J Cordero; D Ayude; M Nogueira; F J Rodriguez-Berrocal; M P de la Cadena
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

10.  Pathological complete response following neoadjuvant radiotherapy and intraperitoneal perfusion chemotherapy for recurrent colon carcinoma: A case report and literature review.

Authors:  Xinyu Bian; Baorui Liu; Yang Yang
Journal:  Oncol Lett       Date:  2016-03-02       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.